LG 101506: Precision RXR Modulator for Nuclear Receptor Signaling Research

Executive Summary: LG 101506 is a small molecule RXR (Retinoid X Receptor) modulator with validated purity (98%) and robust solubility in DMSO (42.05 mg/ml) and ethanol (21.03 mg/ml) under standard laboratory conditions (APExBIO). It is intended strictly for research use, particularly in studies of RXR signaling pathways and nuclear receptor biology. LG 101506 is shipped with temperature control for stability and should be stored at -20°C, with solutions prepared immediately prior to use. RXR modulation by compounds like LG 101506 is instrumental for dissecting mechanisms of metabolism regulation and immune checkpoint biology, notably in cancer models such as triple-negative breast cancer (TNBC) (Zhang et al., 2022). The compound's workflow compatibility and precise action set a new standard for chemical biology research involving RXR.

Biological Rationale

Retinoid X Receptors (RXRs) are nuclear receptors that regulate gene expression in response to endogenous ligands and synthetic modulators. RXR forms heterodimers with other nuclear receptors, orchestrating transcription of genes crucial for metabolism, cellular differentiation, and immune regulation (Zhang et al., 2022). Dysregulation of RXR signaling is implicated in metabolic diseases and cancer, including immune-cold tumors such as triple-negative breast cancer (TNBC).

Modulation of RXR activity can influence downstream pathways such as the PD-L1 immune checkpoint axis. PD-L1 is a key molecule in tumor immune evasion, and its expression is tightly regulated by multiple transcriptional and post-translational mechanisms. Recent studies have identified that RXR-related pathways can impact immunogenicity in cancer cells, providing a rationale for using RXR modulators in immuno-oncology research (Zhang et al., 2022).

Mechanism of Action of LG 101506

LG 101506 is a synthetic small molecule designed to modulate the activity of RXR by binding to its ligand-binding domain. Its chemical structure, (2E,4E,6Z)-7-(3,5-di-tert-butyl-2-(2,2-difluoroethoxy)phenyl)-3-methylocta-2,4,6-trienoic acid, confers high affinity and specificity for the RXR target. Upon binding, LG 101506 influences RXR dimerization, DNA binding, and recruitment of co-activators or co-repressors, ultimately altering gene transcription profiles relevant to metabolism, immune response, and cellular proliferation (APExBIO, 2023).

Compared to other RXR ligands, LG 101506 offers unmatched purity and solubility, minimizing experimental variability and enhancing reproducibility in cell-based and biochemical assays. Its action is confined to RXR modulation, with minimal off-target effects reported under validated in vitro conditions (APExBIO).

Evidence & Benchmarks

• LG 101506 achieves ≥98% purity as confirmed by HPLC analysis at APExBIO under standard conditions (room temperature, neutral pH) (APExBIO).
• Solubility benchmarks: 42.05 mg/ml in DMSO and 21.03 mg/ml in ethanol at 25°C (APExBIO).
• In studies of RXR signaling, modulation by small molecules like LG 101506 has been linked to changes in PD-L1 expression and immune checkpoint activity in cancer models (Zhang et al., 2022).
• RXR modulation is critical for probing transcriptional networks involved in metabolism and immune regulation, establishing LG 101506 as a tool for dissecting these pathways (APExBIO, 2023).
• LG 101506 demonstrates workflow compatibility in both in vitro cell culture and biochemical assay formats, as validated by peer laboratory protocols (APExBIO, 2023).
• Temperature-controlled shipment (blue ice or dry ice) preserves compound stability during transit for up to 5 days (APExBIO).

Applications, Limits & Misconceptions

LG 101506 is primarily used in basic and translational research settings to dissect RXR-mediated signal transduction, metabolism regulation, and immune response pathways. It is particularly valuable in disease models that feature nuclear receptor dysregulation, such as metabolic syndromes and immune-resistant cancers including TNBC. The compound's high purity and solubility facilitate precise dosing and minimize confounding variables in experimental workflows (Biotin.mobi, 2023).

This article extends the mechanistic framework discussed in "Rewiring RXR Signaling Pathways: Strategic Frontiers for Cancer Immunology" by focusing on the specific solubility parameters and workflow integration of LG 101506, while clarifying its role in RXR- and PD-L1–related experimental settings.

See also "LG 101506: RXR Modulator Advancing Nuclear Receptor Biology", which benchmarks purity and solubility across RXR ligands; the present article updates with new workflow data and application boundaries for immune checkpoint research.

Common Pitfalls or Misconceptions

• LG 101506 is not suitable for diagnostic or therapeutic applications; it is for research use only (APExBIO).
• Long-term storage of LG 101506 solutions at room temperature or above -20°C can lead to compound degradation and loss of activity.
• Off-target effects have not been fully characterized in non-mammalian systems; use only in validated cell-based or biochemical assays.
• LG 101506 does not directly inhibit PD-L1; its effects on immune checkpoint pathways are mediated via RXR modulation, not direct protein-protein interaction.
• Improper solvent use (e.g., aqueous buffers) may result in precipitation or reduced compound availability.

Workflow Integration & Parameters

LG 101506 is supplied as an off-white solid and can be reconstituted in DMSO or ethanol. Typical working concentrations range from 1–50 μM for cell-based assays, with stock solutions prepared fresh before each experiment. The compound should be stored at -20°C and protected from light and moisture. For best results, use promptly after reconstitution to avoid degradation (APExBIO).

Temperature-controlled shipping (blue ice or dry ice) ensures stability during transit. The molecular weight (420.53 Da) supports accurate dosing and molarity calculations. Due to its high solubility, LG 101506 is compatible with high-throughput screening and complex dosing regimens in nuclear receptor research (APExBIO, 2023).

Conclusion & Outlook

LG 101506, developed by APExBIO, represents a benchmark RXR modulator for chemical biology and nuclear receptor signaling research. Its superior purity, solubility, and reliable workflow parameters enable high-precision studies in metabolism regulation, immune checkpoint biology, and disease model interrogation. Future research may further elucidate the role of RXR modulation in immune-cold tumor microenvironments and guide rational design of combinatorial therapies. For detailed product specifications and ordering, see the LG 101506 product page.